CSNK1D and melanoma: The analysis focused only on CSNK1A1, CSNK1D, and CSNK1E, not on CSNK1G; CSNK1A1 alterations are dominant in clear cell renal cell carcinoma, and pancreas cancer, CSNK1D in liver and sarcoma, and CSNK1E in melanoma and liver.